The Board heard a substantial review of the agency’s program with WSDA for cannabis product testing and prepared to revise emergency rules on vapor products.
High turnout shattered the concentrate ban bill (at least in the House), expansion of edibles may require work, and location compliance looks set to move forward.
WSLCB leadership was briefed on and discussed cannabis-related legislation active at the legislature, including the agency’s three recently introduced request bills.
The Board discussed craft cannabis legislation, WSLCB’s interagency agreement with WSDA for testing, and WSDA’s stalled organic-equivalent Certified Cannabis standard.
WSLCB Director Rick Garza spoke about restructuring agency enforcement and the Committee heard HB 2296 and HB 2300 regarding cannabidiol (CBD) products.
New details on the WSLCB’s legislative agenda, a Regulators Roundtable redux, plus an update on testing labs, the traceability contract, and the Hillard Heintze report.
Returning from holidaze, the WSLCB, SBOH, and WSDA were all scheduled to convene public events – and Cannabis Observer hosts its first weekly meetup for the legislative session.
CSTF leadership reviewed initial progress reports from its work groups on cannabis laboratory quality standards and proficiency testing.
Agency leadership discussed messaging for Cannabis 2.0, vapor products, hemp/CBD, and traceability while learning the latest numbers from the licensing division.
Participants shared strategies to mitigate costs and phase-in new pesticide and heavy metals testing requirements for cannabis products in Washington state.